← Concentrix Corp
| Annual Trend | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | $152.7m | $182.0m | $145.4m | $295.3m | $240.6m | $327.3m | |
| Accounts receivable, net | $1.1b | $1.2b | $1.4b | $1.9b | $1.9b | $2.0b | |
| Other current assets | $189.2m | $153.1m | $218.5m | $674.4m | $675.1m | $758.1m | |
| Total current assets | $1.4b | $1.5b | $1.8b | $2.9b | $2.8b | $3.1b | |
| Property and equipment, net | $451.6m | $407.1m | $403.8m | $748.7m | $714.5m | $735.5m | |
| Goodwill | $1.8b | $1.8b | $2.9b | $5.1b | $5.0b | $3.7b | |
| Intangible assets, net | $799.0m | $655.5m | $985.6m | $2.8b | $2.3b | $2.0b | |
| Other assets | $620.1m | $578.7m | $573.1m | $928.5m | $942.2m | $991.5m | |
| Deferred tax assets | $47.4m | $48.4m | $48.5m | $72.3m | $218.4m | $317.5m | |
| Income taxes payable | $20.7m | $33.8m | $68.7m | $80.6m | $99.5m | $123.8m | |
| Total stockholders’ equity | $2.3b | $2.6b | $2.7b | $4.1b | $4.0b | $2.7b | |
| Total assets | $5.2b | $5.0b | $6.7b | $12.5b | $12.0b | $10.8b | |
| Total liabilities and stockholders’ equity | $5.2b | $5.0b | $6.7b | $12.5b | $12.0b | $10.8b | |
| Accounts payable | $140.6m | $129.4m | $161.2m | $243.6m | $209.8m | $244.8m | |
| Current portion of long-term debt | $33.8m | $0 | $0 | $2.3m | $2.5m | $65.6m | |
| Accrued compensation and benefits | $419.7m | $453.4m | $507.0m | $731.2m | $706.6m | $765.0m | |
| Other accrued liabilities | $371.1m | $351.6m | $395.3m | $1.0b | $977.3m | $997.2m | |
| Total current liabilities | $1.0b | $968.2m | $1.1b | $2.1b | $2.0b | $2.2b | |
| Long-term debt, net | $1.1b | $802.0m | $2.2b | $4.9b | $4.7b | $4.6b | |
| Other long-term liabilities | $601.9m | $546.4m | $512.0m | $920.5m | $910.3m | $951.0m | |
| Deferred tax liabilities | $153.6m | $109.5m | $105.5m | $414.2m | $312.6m | $296.5m | |
| Total liabilities | $2.9b | $2.4b | $4.0b | $8.3b | $8.0b | $8.0b | |
| Preferred stock, $0.0001 par value, 10,000 shares authorized and no shares issued and outstanding as of November 30, 2025 and 2024, respectively | — | 0 | 0 | 0 | 0 | 0 | |
| Common stock, $0.0001 par value, 250,000 shares authorized; 70,316 and 68,849 shares issued as of November 30, 2025 and 2024, respectively, and 61,739 and 64,238 shares outstanding as of November 30, 2025 and 2024, respectively | — | 5k | 5k | 7k | 7k | 7k | |
| Additional paid-in capital | — | $2.4b | $2.4b | $3.6b | $3.7b | $3.8b | |
| Treasury stock, 8,577 and 4,611 shares as of November 30, 2025 and 2024, respectively | — | ($57.5m) | ($190.8m) | ($272.0m) | ($421.4m) | ($610.2m) | |
| Retained earnings (deficit) | — | $392.5m | $774.1m | $1.0b | $1.2b | ($177.0m) | |
| Accumulated other comprehensive loss | ($3.8m) | ($70.5m) | ($315.7m) | ($191.7m) | ($414.3m) | ($252.5m) |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.